- call +1-201-465-4211
- email sales@mrinsights.biz
Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
Scope of the Report:
The classification of Classical Swine Fever Vaccines includes Tissue Culture Origin and Cell Line Origin. The proportion of Tissue Culture Origin in 2016 is about 60%. And the proportion of Cell Line Origin in 2016 is about 40%.
Market competition is intense WINSUN, CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva etc. are the leader of this industry. With the development of society and the changing of consumer demand, the Classical Swine Fever Vaccines industry will be more and more popular in the future.
The worldwide market for Classical Swine Fever Vaccines is expected to grow at a CAGR of roughly 2.7% over the next five years, will reach 160 million US$ in 2024, from 140 million US$ in 2019, according to a new study.
This report focuses on the Classical Swine Fever Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
WINSUN
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tissue Culture Origin
Cell Line Origin
Market Segment by Applications, can be divided into
Government Tender
Market Sales
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Classical Swine Fever Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Classical Swine Fever Vaccines, with price, sales, revenue and global market share of Classical Swine Fever Vaccines in 2017 and 2018.
Chapter 3, the Classical Swine Fever Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Classical Swine Fever Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Classical Swine Fever Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Classical Swine Fever Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Classical Swine Fever Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Tissue Culture Origin
1.2.2 Cell Line Origin
1.3 Market Analysis by Applications
1.3.1 Government Tender
1.3.2 Market Sales
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 WINSUN
2.1.1 Business Overview
2.1.2 Classical Swine Fever Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 WINSUN Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 CAHIC
2.2.1 Business Overview
2.2.2 Classical Swine Fever Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 CAHIC Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Merial
2.3.1 Business Overview
2.3.2 Classical Swine Fever Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merial Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 MSD Animal Health
2.4.1 Business Overview
2.4.2 Classical Swine Fever Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 MSD Animal Health Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Chopper Biology
2.5.1 Business Overview
2.5.2 Classical Swine Fever Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Chopper Biology Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Ceva
2.6.1 Business Overview
2.6.2 Classical Swine Fever Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Ceva Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 ChengDu Tecbond
2.7.1 Business Overview
2.7.2 Classical Swine Fever Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 ChengDu Tecbond Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Veterinary
2.8.1 Business Overview
2.8.2 Classical Swine Fever Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Veterinary Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Ringpu Biology
2.9.1 Business Overview
2.9.2 Classical Swine Fever Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Qilu Animal
2.10.1 Business Overview
2.10.2 Classical Swine Fever Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Qilu Animal Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 DHN
2.11.1 Business Overview
2.11.2 Classical Swine Fever Vaccines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 DHN Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 CAVAC
2.12.1 Business Overview
2.12.2 Classical Swine Fever Vaccines Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 CAVAC Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Komipharm
2.13.1 Business Overview
2.13.2 Classical Swine Fever Vaccines Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Komipharm Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Agrovet
2.14.1 Business Overview
2.14.2 Classical Swine Fever Vaccines Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Agrovet Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Bioveta
2.15.1 Business Overview
2.15.2 Classical Swine Fever Vaccines Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Bioveta Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Jinyu Bio-Technology
2.16.1 Business Overview
2.16.2 Classical Swine Fever Vaccines Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 Institutul Pasteur
2.17.1 Business Overview
2.17.2 Classical Swine Fever Vaccines Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.18 MVP
2.18.1 Business Overview
2.18.2 Classical Swine Fever Vaccines Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 MVP Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.19 Tecon
2.19.1 Business Overview
2.19.2 Classical Swine Fever Vaccines Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Tecon Classical Swine Fever Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Classical Swine Fever Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Classical Swine Fever Vaccines Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Classical Swine Fever Vaccines Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Classical Swine Fever Vaccines Manufacturer Market Share in 2018
3.3.2 Top 6 Classical Swine Fever Vaccines Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Classical Swine Fever Vaccines Market Analysis by Regions
4.1 Global Classical Swine Fever Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Classical Swine Fever Vaccines Sales and Market Share by Regions (2014-2019)
4.1.2 Global Classical Swine Fever Vaccines Revenue and Market Share by Regions (2014-2019)
4.2 North America Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
4.3 Europe Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
4.5 South America Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
5 North America Classical Swine Fever Vaccines by Country
5.1 North America Classical Swine Fever Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Classical Swine Fever Vaccines Sales and Market Share by Country (2014-2019)
5.1.2 North America Classical Swine Fever Vaccines Revenue and Market Share by Country (2014-2019)
5.2 United States Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
5.3 Canada Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
5.4 Mexico Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
6 Europe Classical Swine Fever Vaccines by Country
6.1 Europe Classical Swine Fever Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Classical Swine Fever Vaccines Sales and Market Share by Country (2014-2019)
6.1.2 Europe Classical Swine Fever Vaccines Revenue and Market Share by Country (2014-2019)
6.2 Germany Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
6.3 UK Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
6.4 France Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
6.5 Russia Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
6.6 Italy Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
7 Asia-Pacific Classical Swine Fever Vaccines by Country
7.1 Asia-Pacific Classical Swine Fever Vaccines Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Classical Swine Fever Vaccines Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Classical Swine Fever Vaccines Revenue and Market Share by Country (2014-2019)
7.2 China Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
7.3 Japan Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
7.4 Korea Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
7.5 India Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
8 South America Classical Swine Fever Vaccines by Country
8.1 South America Classical Swine Fever Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Classical Swine Fever Vaccines Sales and Market Share by Country (2014-2019)
8.1.2 South America Classical Swine Fever Vaccines Revenue and Market Share by Country (2014-2019)
8.2 Brazil Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
8.3 Argentina Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
8.4 Colombia Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
9 Middle East and Africa Classical Swine Fever Vaccines by Countries
9.1 Middle East and Africa Classical Swine Fever Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Classical Swine Fever Vaccines Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Classical Swine Fever Vaccines Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
9.3 Turkey Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
9.4 Egypt Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
9.5 Nigeria Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
9.6 South Africa Classical Swine Fever Vaccines Sales and Growth Rate (2014-2019)
10 Global Classical Swine Fever Vaccines Market Segment by Type
10.1 Global Classical Swine Fever Vaccines Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Classical Swine Fever Vaccines Sales and Market Share by Type (2014-2019)
10.1.2 Global Classical Swine Fever Vaccines Revenue and Market Share by Type (2014-2019)
10.2 Tissue Culture Origin Sales Growth and Price
10.2.1 Global Tissue Culture Origin Sales Growth (2014-2019)
10.2.2 Global Tissue Culture Origin Price (2014-2019)
10.3 Cell Line Origin Sales Growth and Price
10.3.1 Global Cell Line Origin Sales Growth (2014-2019)
10.3.2 Global Cell Line Origin Price (2014-2019)
11 Global Classical Swine Fever Vaccines Market Segment by Application
11.1 Global Classical Swine Fever Vaccines Sales Market Share by Application (2014-2019)
11.2 Government Tender Sales Growth (2014-2019)
11.3 Market Sales Sales Growth (2014-2019)
12 Classical Swine Fever Vaccines Market Forecast (2019-2024)
12.1 Global Classical Swine Fever Vaccines Sales, Revenue and Growth Rate (2019-2024)
12.2 Classical Swine Fever Vaccines Market Forecast by Regions (2019-2024)
12.2.1 North America Classical Swine Fever Vaccines Market Forecast (2019-2024)
12.2.2 Europe Classical Swine Fever Vaccines Market Forecast (2019-2024)
12.2.3 Asia-Pacific Classical Swine Fever Vaccines Market Forecast (2019-2024)
12.2.4 South America Classical Swine Fever Vaccines Market Forecast (2019-2024)
12.2.5 Middle East and Africa Classical Swine Fever Vaccines Market Forecast (2019-2024)
12.3 Classical Swine Fever Vaccines Market Forecast by Type (2019-2024)
12.3.1 Global Classical Swine Fever Vaccines Sales Forecast by Type (2019-2024)
12.3.2 Global Classical Swine Fever Vaccines Market Share Forecast by Type (2019-2024)
12.4 Classical Swine Fever Vaccines Market Forecast by Application (2019-2024)
12.4.1 Global Classical Swine Fever Vaccines Sales Forecast by Application (2019-2024)
12.4.2 Global Classical Swine Fever Vaccines Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Classical Swine Fever Vaccines Picture
Table Product Specifications of Classical Swine Fever Vaccines
Figure Global Sales Market Share of Classical Swine Fever Vacci
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
